Get The Support That You Need

Applying to MedTech Syndicates is very simple. We just need you to fill in our on boarding form.

Yes. Companies conducting a Testing the Waters campaign with MedTech Syndicates are required to pay an upfront onboarding fee of $2,500. This covers initial setup, compliance review, and Bad Actor checks, along with the collection of your basic company information.

To maximize your chances of success, you should have:

1. A well-designed pitch deck

2. A short introductory video (2–3 minutes)

3. Participation in a pitch panel with clinicians and investors

If your Testing the Waters campaign is successful and we proceed with a formal raise under Reg CF, Reg D 506(c), or Reg A+, MedTech Syndicates charges a platform fee of 8% of the total amount raised. This 8% may be structured as a combination of cash and equity depending on the agreement.

MedTech Syndicates provides access to a global network of clinicians who understand your product’s value. Through our SEC-compliant partnerships, you can raise from both accredited and non-accredited investors—legally and efficiently.

We help with: Structuring under Reg CF, Reg D 506(c), or Reg A+; managing compliance, filings, and broker-dealer oversight; conducting “Testing the Waters” to gauge clinician interest before launch; and hosting clinician-led webinars and pitch panels.

“Testing-the-Waters” refers to the practice of gauging investor interest in a proposed securities offering before fully committing to the the formal offering process (e.g. SEC registration or full compliance). It allows a company to present a preview of the opportunity, solicit feedback and measure demand, refine messaging and terms, and avoid the cost of going all-in prematurely.

In securities law, TTW typically involves oral or written communications with potential investors (especially institutional or sophisticated investors) to assess their appetite — without accepting binding commitments.

Reg CF allows startups to raise up to $5 million per year from the general public—including clinicians who may not be accredited. All campaigns must be hosted on licensed portals such as MedTech Syndicates.

Reg D 506(c) allows public marketing of your raise to accredited investors only. You can raise an unlimited amount, but each investor must be verified. Ideal for later-stage companies, higher ticket sizes, and clinician networks with many accredited professionals.

Reg A+ allows companies to raise up to $75 million annually from both accredited and non-accredited investors. It’s often viewed as a “mini-IPO,” with optional liquidity for early shareholders and enhanced visibility with regulators and investors.

We’ll guide you based on raise size, target investor profile (clinicians, retail, or institutional), regulatory timeline and budget, liquidity goals, and potential for secondary sales.

Yes. Under Reg CF, Reg A+, and Reg D 506(c), general solicitation (public marketing of investment opportunities) is fully permitted—provided that:

• Reg CF and Reg A+ offerings are conducted through FINRA-registered portals.

• Reg D 506(c) offerings verify that all investors are accredited.

Yes.

• Under Reg CF, both accredited and non-accredited clinicians can invest, subject to annual limits based on income and net worth.

• Under Reg D 506(c), only accredited clinicians may invest after verification.

• Under Reg A+, both accredited and non-accredited investors can participate in SEC-qualified offerings.

Each offering undergoes SEC and FINRA compliance review, verification of company materials, disclosures, and financials, and independent clinician validation of the medical and commercial case. This protects both investors and issuers while ensuring eligibility for public marketing.

Companies must present their story professionally to attract clinician investors. Before launch, each company should have:

• Investor Slide Deck: A clear, concise 10–15 slide presentation outlining the problem, solution, team, market, traction, and financials.

• Video Introduction (2–3 minutes): A professional video where the founder introduces the company, explains the clinical problem, and showcases the technology or solution.

• Pitch Panel Participation: Founders must be available for a live or recorded clinician-led webinar where the opportunity is discussed and validated.

• Company FAQ: A written summary addressing common investor questions (market, competition, IP, regulatory pathway, clinical data, and business model).

• Supporting Documentation: Data, patents, regulatory submissions, and financials sufficient for due diligence review.
  These materials are essential for compliance and credibility, ensuring both MedTech Syndicates and potential investors can evaluate the opportunity thoroughly before launch.

Depending on the regulation:

• Reg CF – approximately 8–10 weeks;

• Reg D 506(c) – approximately 4–6 weeks;

• Reg A+ – 3–6 months (due to SEC qualification).

Typical costs include legal and compliance filings, broker-dealer and technology fees, and marketing and investor relations management.

Investors receive digital share certificates within 30 days, and you’ll continue to engage them through updates and webinars. MedTech Syndicates manages all ongoing compliance and investor communication.